… Since triple combination therapy should be prescribed to patients with COPD only when …
the superiority of triple therapy over other therapeutic options (particularly in patients at low risk …

… or severe COPD exacerbations and better … dual therapy with fluticasone furoate–vilanterol
or the dual bronchodilator umeclidinium–vilanterol among patients with symptomatic COPD …

… of COPD Treatment (IMPACT) trial involving more than 10,000 patients with chronic obstructive
pulmonary disease (COPD), … or severe COPD exacer- bations. Since a large fraction of …

… ; KRONOS = triple therapy with budesonide/glycopyrrolate/… versus dual therapies in chronic
obstructive pulmonary disease … inhaled triple therapy versus dual bronchodilator therapy in …

… in people with moderate to severe chronic obstructive pulmonary disease (COPD) to control
… A number of LABA/LAMA combinations are now available for clinical use in COPD. However…

… In addition to the apparent increase in lung cancer observed in smokers, we now
recognize that patients with COPD have a substantial burden of cardiovascular, metabolic, …

… therapy should be prescribed to patients with COPD only … and other relevant outcomes in
patients with COPD. … strategy for COPD that suggest to use triple therapy in patients who have …

… triple therapy on the outcomes of advanced COPD patients … triple therapy can help patients
with advanced COPD achieve … of life compared with LABA/LAMA or ICS/LAMA dual therapy. …

… Although patients who consult their physicians more frequently than average may be …
patients with COPD, despite the use of dual or triple therapy. A percentage of patients with COPD …

… morbidity and mortality rates in COPD patients. The present study shows that compared with
single-inhaler dual therapy, single-inhaler triple therapy significantly reduced the frequency …